Cromwell Holdings LLC Regeneron Pharmaceuticals, Inc. Transaction History
Cromwell Holdings LLC
- $152 Million
- Q3 2024
A detailed history of Cromwell Holdings LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cromwell Holdings LLC holds 233 shares of REGN stock, worth $187,408. This represents 0.16% of its overall portfolio holdings.
Number of Shares
233
Previous 233
-0.0%
Holding current value
$187,408
Previous $244,000
-0.0%
% of portfolio
0.16%
Previous 0.15%
Shares
1 transactions
Others Institutions Holding REGN
# of Institutions
1,505Shares Held
85.3MCall Options Held
908KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA9.32MShares$7.5 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.79 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$6.02 Billion0.65% of portfolio
-
State Street Corp Boston, MA4.84MShares$3.89 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.46 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $86.2B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...